DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 168 filers reported holding DIPLOMAT PHARMACY INC in Q2 2016. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $17,000 | -19.0% | 3,500 | 0.0% | 0.00% | – |
| Q2 2019 | $21,000 | +5.0% | 3,500 | 0.0% | 0.00% | – |
| Q1 2019 | $20,000 | -67.2% | 3,500 | -22.2% | 0.00% | – |
| Q4 2018 | $61,000 | -29.9% | 4,500 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $87,000 | -24.3% | 4,500 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $115,000 | +26.4% | 4,500 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $91,000 | +1.1% | 4,500 | 0.0% | 0.00% | – |
| Q4 2017 | $90,000 | -3.2% | 4,500 | 0.0% | 0.00% | – |
| Q3 2017 | $93,000 | +38.8% | 4,500 | 0.0% | 0.00% | – |
| Q2 2017 | $67,000 | -6.9% | 4,500 | 0.0% | 0.00% | – |
| Q1 2017 | $72,000 | +26.3% | 4,500 | 0.0% | 0.00% | – |
| Q4 2016 | $57,000 | -54.8% | 4,500 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $126,000 | -20.3% | 4,500 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $158,000 | +28.5% | 4,500 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $123,000 | -20.1% | 4,500 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $154,000 | +19.4% | 4,500 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $129,000 | +186.7% | 4,500 | +350.0% | 0.00% | – |
| Q2 2015 | $45,000 | +28.6% | 1,000 | 0.0% | 0.00% | – |
| Q1 2015 | $35,000 | +29.6% | 1,000 | 0.0% | 0.00% | – |
| Q4 2014 | $27,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|